Charles Murray
Charles Murray
Royal Free Hospital
Verified email at
Cited by
Cited by
Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study
CDR Murray, NM Martin, M Patterson, SA Taylor, MA Ghatei, MA Kamm, ...
Gut 54 (12), 1693-1698, 2005
Effect of acute physical and psychological stress on gut autonomic innervation in irritable bowel syndrome
CDR Murray, J Flynn, L Ratcliffe, MR Jacyna, MA Kamm, AV Emmanuel
Gastroenterology 127 (6), 1695-1703, 2004
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
NA Kennedy, GA Heap, HD Green, B Hamilton, C Bewshea, GJ Walker, ...
The lancet Gastroenterology & hepatology 4 (5), 341-353, 2019
Ghrelin for the gastroenterologist: history and potential
CDR Murray, MA Kamm, SR Bloom, AV Emmanuel
Gastroenterology 125 (5), 1492-1502, 2003
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
NA Kennedy, GR Jones, CA Lamb, R Appleby, I Arnott, RM Beattie, ...
Gut 69 (6), 984-990, 2020
Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial
C Mowat, I Arnott, A Cahill, M Smith, T Ahmad, S Subramanian, S Travis, ...
The lancet Gastroenterology & hepatology 1 (4), 273-282, 2016
Prokineticin-2, motilin, ghrelin and metoclopramide: prokinetic utility in mouse stomach and colon
AK Bassil, NB Dass, CD Murray, A Muir, GJ Sanger
European journal of pharmacology 524 (1-3), 138-144, 2005
Relapse after withdrawal from anti‐TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta‐analysis
NA Kennedy, B Warner, EL Johnston, L Flanders, P Hendy, NS Ding, ...
Alimentary pharmacology & therapeutics 43 (8), 910-923, 2016
Gastrointestinal manifestations of systemic sclerosis
AB Shreiner, C Murray, C Denton, D Khanna
Journal of scleroderma and related disorders 1 (3), 247-256, 2016
Clinical features and HLA association of 5-aminosalicylate (5-ASA)-induced nephrotoxicity in inflammatory bowel disease
GA Heap, K So, M Weedon, N Edney, C Bewshea, A Singh, V Annese, ...
Journal of Crohn's and Colitis 10 (2), 149-158, 2016
Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn's disease (METRIC): a …
SA Taylor, S Mallett, G Bhatnagar, R Baldwin-Cleland, S Bloom, A Gupta, ...
The lancet Gastroenterology & hepatology 3 (8), 548-558, 2018
Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis
N Hansi, N Thoua, M Carulli, K Chakravarty, S Lal, A Smyth, A Herrick, ...
Clin Exp Rheumatol 32 (6 Suppl 86), 214-21, 2014
CMV in the gut: a critical review of CMV detection in the immunocompetent host with colitis
AL Goodman, CD Murray, J Watkins, PD Griffiths, DP Webster
European Journal of Clinical Microbiology & Infectious Diseases 34 (1), 13-18, 2015
The effect of khat (Catha edulis) as an appetite suppressant is independent of ghrelin and PYY secretion
CDR Murray, CW Le Roux, AV Emmanuel, JM Halket, AM Przyborowska, ...
Appetite 51 (3), 747-750, 2008
A randomized, double-blind, placebo-controlled, parallel-group, pilot study of cannabidiol-rich botanical extract in the symptomatic treatment of ulcerative colitis
PM Irving, T Iqbal, C Nwokolo, S Subramanian, S Bloom, N Prasad, A Hart, ...
Inflammatory bowel diseases 24 (4), 714-724, 2018
Sustained benefit from intravenous immunoglobulin therapy for gastrointestinal involvement in systemic sclerosis
J Raja, SI Nihtyanova, CD Murray, CP Denton, VH Ong
Rheumatology 55 (1), 115-119, 2016
UK guideline on transition of adolescent and young persons with chronic digestive diseases from paediatric to adult care
AJ Brooks, PJ Smith, R Cohen, P Collins, A Douds, V Forbes, DR Gaya, ...
Gut 66 (6), 988-1000, 2017
Amitriptyline modifies the visceral hypersensitivity response to acute stress in the irritable bowel syndrome
NM Thoua, CDR Murray, WJ Winchester, AJ Roy, MCL Pitcher, MA Kamm, ...
Alimentary pharmacology & therapeutics 29 (5), 552-560, 2009
Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management
RE Rossi, I Parisi, EJ Despott, AK Burroughs, J O'Beirne, D Conte, ...
World Journal of Gastroenterology: WJG 20 (46), 17352, 2014
The effect of different macronutrient infusions on appetite, ghrelin and peptide YY in parenterally fed patients
CD Murray, CW le Roux, C Gouveia, P Bassett, MA Ghatei, SR Bloom, ...
Clinical Nutrition 25 (4), 626-633, 2006
The system can't perform the operation now. Try again later.
Articles 1–20